United Technologies is taking share from competitors like General Electirc.
DuPont shares were on the rise Tuesday following its latest quarterly results.
A slew of corporate earnings and closely watched Federal Reserve meeting are in focus for the week of July 25.
Tesla CEO Elon Musk is a visionary who thinks big, but don't trust his numbers, says Jim Cramer.
Shares of Relypsa surged on news of a takeover by Galenica, the owner of Switzerland's biggest pharmacy network.
Biogen shares could be on a turnaround trajectory after a year of disappointments.
The departure of Biogen's CEO could lead to a sale of the biotech company, or a renewed push to boost its own M&A activities.
MIT's Smart 50 list recognizes companies for their combination of innovative technology and effective management, and it includes 13 pharmaceutical and biotech firms this year.
Jim Cramer was encouraged by the slew of drug approvals Valeant Pharmaceuticals received from the FDA.